Paul Raeburn

First Amendment Claims Seen as Rx for Drug Makers, Headache for Consumers

First Amendment Claims Seen as Rx for Drug Makers, Headache for Consumers

On Oct. 26, 2005, Alfred Caronia, a sales consultant for a little-known pharmaceutical company based in California, met with a doctor to discuss promotion of one of the firm’s  drugs. The drug, a depressant called Xyrem, had been approved by the U.S. Food and Drug Administration to treat only certain patients with the sleep disorder…